CYCLO THERAPEUTICS INC
CUSIP 23254X110
Cyclo Therapeutics Inc has 4 institutional holders in Filings Flow’s 13F database, together reporting 90.3K shares worth $46,942 as of Q4 2022. The largest reported holders are Citadel Advisors LLC, Ubs Group AG, and Concourse Financial Group Securities, Inc..
Institutional Holders
4
Q4 2022
Reported Value
$46,942
Ticker
unmapped
private placement or foreign
Quarters Tracked
3
Ownership Trend
Institutional holders
Total reported value
Holders
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $1,637 | 11.7K | Q4 2024 |
| UBS Group AG$666.3B AUM | 0.00% | $13 | 175 | Q4 2024 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.